Gm(1) and Gm(2) immunglobulin allotypes in patients with malignant melanoma
- 1 January 1975
- journal article
- Published by Springer Nature in Human Genetics
- Vol. 28 (3) , 177-181
- https://doi.org/10.1007/bf00278542
Abstract
Gm allotype markers were determined in sera from 71 melanoma patients and 400 control persons. There was no significant difference between both groups in Gm distribution. The results were compared to a recent report. Furthermore, in 25 melanoma patients the capacity of serum to interfere with cell-mediated cytotoxicity (CMC) of autologous lymphocytes was determined and related to the Gm allotype.Keywords
This publication has 21 references indexed in Scilit:
- Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.1975
- LYMPHOID CELLS MEDIATING TUMOR-SPECIFIC CYTOTOXICITY TO CARCINOMA OF THE URINARY BLADDERThe Journal of Experimental Medicine, 1974
- Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor ImmunityPublished by Elsevier ,1974
- Human Immunoglobulins: Classes, Subclasses, Genetic Variants, and IdiotypesPublished by Elsevier ,1973
- Lymphocyte Mediated Cytotoxicity in Vitro. Induction and Inhibition by Humoral Antibody and Nature of Effector CellsImmunological Reviews, 1972
- Antibody in the Induction and Inhibition of Lymphocyte CytotoxicityImmunological Reviews, 1972
- Serogenetic investigations on malignant melanomas with reference to the incidence of AB0 system, Rh system, Gm, Inv, Hp and Gc systemsHuman Genetics, 1972
- Melanoma in RelativesJAMA, 1971
- Multiple malignant melanoma. Report of a patient with four primary malignant cutaneous melanomasBritish Journal of Plastic Surgery, 1971
- Malignant Melanoma in SiblingsArchives of Dermatology, 1968